On February 27, 2026, the European Chemicals Agency (ECHA) published its annual evaluation statistics. The data shows that between 2009 and 2025, ECHA completed compliance checks for over 30% of chemical substances registered before 2019 with an annual tonnage exceeding 100 tonnes. This involved a cumulative review of 16,100 registration dossiers, covering 2,380 substances, which accounts for 23.5% of all submitted dossiers.
Work Achievements in 2025
I. Dossier Evaluation Progress
1. Compliance Check Implementation
|
Check Type |
Quantity |
Coverage |
|
Comprehensive Compliance Check |
190 |
1,170+ dossiers, 179 substances |
|
Targeted Compliance Check |
24 |
- |
|
Total |
214 |
Nearly 1,200 dossiers, 196 substances |
Key inspection targets:
- High-level hazard endpoints for high-tonnage substances.
- Substances or groups of substances of potential concern.
- Companies that left joint submissions and submitted individual dossiers (13 dossiers inspected, covering 11 substances, with almost all found non-compliant).
2. Data Requirements and Focus Points
ECHA requested significant hazard data to clarify concerns regarding:
- Human health hazards
- Environmental hazards
- Reproductive toxicity
- Mutagenicity
3. 2025 Dossier Evaluation Output
|
Evaluation Type |
Quantity |
Coverage |
|
Comprehensive Compliance Checks (CCHs) |
190 |
274 substances |
|
Testing Proposal Examinations (TPEs) |
108 |
4. Decisions Adopted:
- Decisions related to compliance checks: 208
- Decisions on testing proposal examinations: 115
- Total: 323 decisions
II. Substance Evaluation Progress
In 2025, ECHA made progress on 43 substances: the Evaluating Member States initiated evaluation on 10 new substances; ECHA adopted 12 substance evaluation decisions, requesting further information for 18 substances; and the Evaluating Member States completed the follow-up evaluation for 7 substances. Additionally, the evaluation was concluded (conclusion documents published) for 14 substances: among these, it was recommended to consider further risk management measures for 12 substances, while the necessary measures were already in place (or no measures were needed) for 2 substances.
III. Further information requests & Follow-up
Regarding the mechanism for requesting further information, ECHA completed the follow-up evaluation for 241 substances in 2025. Notably, approximately 70% of companies had submitted the requested supplementary information to the Agency; the remaining 30% of cases were referred to Member States for enforcement action. After receiving supplementary data from companies, ECHA referred over 15% of the cases to the competent authorities of the Member States, recommending consideration of further risk management measures.
